This inventor holds 1 USPTO granted patent. Top assignee: Obi Pharma Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Shu-Yu Lee
Introduction
Shu-Yu Lee is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of human antibodies. His work focuses on creating innovative solutions for cancer therapies and diagnostics.
Latest Patents
Shu-Yu Lee holds a patent for a pharmaceutical composition that comprises antibodies or antigen-binding fragments that target Globo H, stage-specific embryonic antigen 3 (SSEA-3), and stage-specific embryonic antigen 4 (SSEA-4). This patent outlines methods of use that include cancer therapies and diagnostics. The antibodies developed can bind to specific cancer cell surfaces, making them valuable in treating various carcinomas, including sarcoma, skin cancer, leukemia, and many others.
Career Highlights
Shu-Yu Lee is associated with Obi Pharma Inc., where he continues to advance his research and development efforts. His work has the potential to impact the treatment landscape for numerous types of cancer, providing new hope for patients.
Collaborations
Shu-Yu Lee collaborates with notable colleagues, including Cheng-Der Tony Yu and Woan Eng Chan. Their combined expertise enhances the innovative capabilities of their research team.
Conclusion
Shu-Yu Lee's contributions to the field of pharmaceuticals, particularly in cancer treatment, highlight his role as a leading inventor. His innovative work continues to pave the way for advancements in medical science.